Immunology of Cell Death in Cancer Immunotherapy

被引：11
作者：
Galluzzi, Lorenzo [1 ,2 ,3 ,4 ,5 ]
Garg, Abhishek D. [6 ]
机构：
[1] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA
[2] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA
[3] Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA
[4] Yale Sch Med, Dept Dermatol, New Haven, CT 06520 USA
[5] Univ Paris, F-75006 Paris, France
[6] Katholieke Univ Leuven, Dept Cellular & Mol Med CMM, Cell Stress & Immun CSI Lab, B-3000 Leuven, Belgium
来源：
CELLS | 2021年 / 10卷 / 05期
关键词：
immuno-oncology; immune-checkpoint blockers; necroptosis; apoptosis; inflammation; biomarkers; STRESS;
D O I：
10.3390/cells10051208
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：7
相关论文
共 73 条
  • [1] The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
    Aaes, Tania Love
    Vandenabeele, Peter
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (03) : 843 - 860
  • [2] Prospects for combined use of oncolytic viruses and CAR T-cells
    Ajina, Adam
    Maher, John
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Immunotherapy biomarkers: the long and winding road
    Alban, Tyler J.
    Chan, Timothy A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (06) : 323 - 324
  • [4] First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
    Anna, Francois
    Bole-Richard, Elodie
    LeMaoult, Joel
    Escande, Marie
    Lecomte, Martin
    Certoux, Jean-Made
    Souque, Philippe
    Garnache, Francine
    Adotevi, Olivier
    Langlade-Demoyen, Pierre
    Loustau, Maria
    Caumartin, Julien
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [5] Immunostimulatory monoclonal antibodies in cancer therapy
    Aranda, Fernando
    Vacchelli, Erika
    Eggermont, Alexander
    Galon, Jerome
    Fridman, Wolf Herve
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    [J]. ONCOIMMUNOLOGY, 2014, 3 (02):
  • [6] Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
    Buque, Aitziber
    Bloy, Norma
    Perez-Lanzon, Maria
    Iribarren, Kristina
    Humeau, Juliette
    Pol, Jonathan G.
    Levesque, Sarah
    Mondragon, Laura
    Yamazaki, Takahiro
    Sato, Ai
    Aranda, Fernando
    Durand, Sylvere
    Boissonnas, Alexandre
    Fucikova, Jitka
    Senovilla, Laura
    Enot, David
    Hensler, Michal
    Kremer, Margerie
    Stoll, Gautier
    Hu, Yang
    Massa, Chiara
    Formenti, Silvia C.
    Seliger, Barbara
    Elemento, Olivier
    Spisek, Radek
    Andre, Fabrice
    Zitvogel, Laurence
    Delaloge, Suzette
    Kroemer, Guido
    Galluzzi, Lorenzo
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [7] High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients
    Cao, Dedong
    Xu, Huilin
    Xu, Ximing
    Guo, Tao
    Ge, Wei
    [J]. ONCOIMMUNOLOGY, 2019, 8 (09):
  • [8] Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)
    Cao, Rui
    Yuan, Lushun
    Ma, Bo
    Wang, Gang
    Tian, Ye
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 1 - 18
  • [9] Metabolic barriers to cancer immunotherapy
    DePeaux, Kristin
    Delgoffe, Greg M.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2021, 21 (12) : 785 - 797
  • [10] Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
    Dosset, Magalie
    Joseph, Elodie Lauret-Marie
    Vargas, Thaiz Rivera
    Apetoh, Lionel
    [J]. CELLS, 2020, 9 (07) : 1 - 24
12345678